Robert B. Wilson — Endo Lab

2020

Reprogramming of Mesothelial-Mesenchymal Transition in Chronic Peritoneal Diseases by Estrogen Receptor Modulation and TGF-β1 Inhibition.

International journal of molecular sciences ·doi:10.3390/ijms21114158

In chronic peritoneal diseases, mesothelial-mesenchymal transition is determined by cues from the extracellular environment rather than just the cellular genome. The transformation of peritoneal mesothelial cells and other host cells into m…

review 2018

Hypoxia, cytokines and stromal recruitment: parallels between pathophysiology of encapsulating peritoneal sclerosis, endometriosis and peritoneal metastasis

Pleura and peritoneum ·doi:10.1515/pp-2018-0103

Peritoneal response to various kinds of injury involves loss of peritoneal mesothelial cells (PMC), danger signalling, epithelial-mesenchymal transition and mesothelial-mesenchymal transition (MMT). Encapsulating peritoneal sclerosis (EPS),…

article 1967

Serosal endometriosis of Fallopian tubes

American journal of obstetrics and gynecology ·doi:10.1016/0002-9378(67)90406-1

article 1966

Endometrioid sarcoma (“stromal endometriosis”)

American journal of obstetrics and gynecology ·doi:10.1016/0002-9378(66)90632-6

article 1960

Primary endometriosis of the cervix

American journal of obstetrics and gynecology ·doi:10.1016/0002-9378(60)90635-9

article 1947

Medical versus Surgical Treatment of Pelvic Inflammatory Disease

·doi:10.1016/s0039-6109(16)32187-9

article 1941

Pelvic pain

·doi:10.1016/s0002-9378(41)90168-0